Genistein consistently reduced the expression of CD133, CD44, and β-catenin in 1,2-dimethylhydrazine (DMH)-induced colorectal cancer in rats, suggesting that genistein might inhibit DMH-induced colon cancer stem cells (CSCs) [46,47]. The gene discussed is PROM1; the disease is colorectal cancer.